142 related articles for article (PubMed ID: 36048196)
21. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
[No Abstract] [Full Text] [Related]
22. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
23. Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision.
Naffouje S; Sabesan A; Powers BD; Dessureault S; Sanchez J; Schell M; Imanirad I; Sahin I; Xie H; Felder S
Clin Colorectal Cancer; 2021 Sep; 20(3):e155-e164. PubMed ID: 33775560
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II-III rectal cancer: A population-based study.
Ke TW; Liao YM; Chiang HC; Chang SC; Wang PH; Chen YY; Chen WT; Chien CR
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e234-40. PubMed ID: 24571424
[TBL] [Abstract][Full Text] [Related]
25. What Is the Utility of Restaging Imaging for Patients With Clinical Stage II/III Rectal Cancer After Completion of Neoadjuvant Chemoradiation and Prior to Proctectomy?
Hendrick LE; Buckner JD; Guerrero WM; Shibata D; Hinkle NM; Monroe JJ; Glazer ES; Deneve JL; Dickson PV
Am Surg; 2021 Feb; 87(2):242-247. PubMed ID: 32927959
[TBL] [Abstract][Full Text] [Related]
26. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
[TBL] [Abstract][Full Text] [Related]
28. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment Tumor Thickness as a Predictor of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy for Stage II/III Rectal Adenocarcinoma.
Xu B; Chen Y; Guo Y; Zhou D; Yue Z; Duan Q; Yang Y; Guan G; Chi P; Lin C
Am J Clin Oncol; 2018 Jun; 41(6):601-606. PubMed ID: 27672742
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens.
de la Fuente SG; Manson RJ; Ludwig KA; Mantyh CR
J Gastrointest Surg; 2009 Feb; 13(2):269-74. PubMed ID: 18850250
[TBL] [Abstract][Full Text] [Related]
32. Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection.
Dossa F; Acuna SA; Rickles AS; Berho M; Wexner SD; Quereshy FA; Baxter NN; Chadi SA
JAMA Oncol; 2018 Jul; 4(7):930-937. PubMed ID: 29710274
[TBL] [Abstract][Full Text] [Related]
33. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
[TBL] [Abstract][Full Text] [Related]
34. Ten-year survival after pathologic complete response in rectal adenocarcinoma.
Sell NM; Qwaider YZ; Goldstone RN; Cauley CE; Cusack JC; Ricciardi R; Bordeianou LG; Berger DL; Kunitake H
J Surg Oncol; 2021 Jan; 123(1):293-298. PubMed ID: 33022797
[TBL] [Abstract][Full Text] [Related]
35. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study.
Chung MJ; Lee JH; Lee JH; Kim SH; Song JH; Jeong S; Yu M; Nam TK; Jeong JU; Jang HS
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):438-448. PubMed ID: 30244158
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.
Ye W; Shi L; Qian L; Sun Y; Sun X
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108
[TBL] [Abstract][Full Text] [Related]
39. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
[TBL] [Abstract][Full Text] [Related]
40. Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Yu S; Mamtani R; O'Hara MH; O'Dwyer PJ; Margalit O; Giantonio BJ; Shmueli E; Reiss KA; Boursi B
Clin Colorectal Cancer; 2021 Jun; 20(2):121-129. PubMed ID: 33608161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
